Quantitative Proteomics Analysis of Plasmodium vivax Induced Alterations in Human Serum during the Acute and Convalescent Phases of Infection

Quantitative Proteomics Analysis of Plasmodium vivax Induced Alterations in Human Serum during the Acute and Convalescent Phases of Infection

Abstract The radial distribution of Plasmodium vivax malaria burden has evoked enormous concern among the global research community. In this study, we have investigated the serum proteome alterations in non-severe vivax malaria patients before and during patient recuperation starting from the early...

Full description

Bibliographic Details
Main Authors:	Sandipan Ray, Sandip K. Patel, Apoorva Venkatesh, Gangadhar Chatterjee, Naziya N. Ansari, Nithya J. Gogtay, Urmila M. Thatte, Prajakta Gandhe, Santosh G. Varma, Swati Patankar, Sanjeeva Srivastava
Format:	Article
Language:	English
Published:	Nature Publishing Group 2017-06-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-017-04447-5

Similar Items

Proteomic investigation of falciparum and vivax malaria for identification of surrogate protein markers.
by: Sandipan Ray, et al.
Published: (2012-01-01)

Comprehensive proteomics investigation of P. vivax-infected human plasma and parasite isolates
by: Apoorva Venkatesh, et al.
Published: (2020-03-01)

A study comparing trial registry entries of randomized controlled trials with publications of their results in a high impact factor journal: The Journal of the American Medical Association
by: Poorwa Wandalkar, et al.
Published: (2017-01-01)

Alterations in cytokines and haematological parameters during the acute and convalescent phases of Plasmodium falciparum and Plasmodium vivax infections
by: Rodrigo Nunes Rodrigues-da-Silva, et al.
Published: (2014-04-01)

Compliance of Mumbai-based clinical trial sites with the Quality Council of India guidelines and evaluation of the challenges faced by the investigators
by: Brinal Figer, et al.
Published: (2021-01-01)

Do clinical trials conducted in India match its healthcare needs? An audit of the Clinical Trials Registry of India
by: Mansi Chaturvedi, et al.
Published: (2017-01-01)

Valbenazine: Drug review
by: Mahanjit Konwar, et al.
Published: (2017-01-01)

Regulatory requirements for clinical trials in India: What academicians need to know
by: Nithya J Gogtay, et al.
Published: (2017-01-01)

A prospective study to assess the association between genotype, phenotype and Prakriti in individuals on phenytoin monotherapy
by: Saket J. Thaker, et al.
Published: (2017-01-01)

Procalcitonin-guided antibiotic usage - addressing heterogeneity in meta-analysis
by: Amit Ravindra Birajdar, et al.
Published: (2018-01-01)

An audit of minutes of Subject Expert Committee meetings as a metric to assess the clinical research roadmap of India
by: Parvan A Shetty, et al.
Published: (2019-01-01)

A two-year evaluation of the minutes of Investigational New Drug committee meetings
by: Jeffrey Pradeep Raj, et al.
Published: (2021-01-01)

Use of computerized tests to evaluate psychomotor performance in children with specific learning disabilities in comparison to normal children
by: Santosh Taur, et al.
Published: (2014-01-01)

Evaluation of pharmacokinetics of single-dose primaquine in undernourished versus normally nourished children diagnosed with Plasmodium vivax malaria in Mumbai
by: N J Gogtay, et al.
Published: (2021-01-01)

Recruitment and retention of the participants in clinical trials: Challenges and solutions
by: Nayan Chaudhari, et al.
Published: (2020-01-01)

Investigator-initiated studies: Challenges and solutions
by: Mahanjit Konwar, et al.
Published: (2018-01-01)

The global initiative for asthma guidelines (2019): change in the recommendation for the management of mild asthma based on the SYGMA-2 trial – A critical appraisal
by: Sujeet Rajan, et al.
Published: (2020-01-01)

Investigator preparedness for monitoring and audits
by: Renju Ravi, et al.
Published: (2018-01-01)

Methotrexate-induced pneumonitis and myocarditis
by: Subhash Yadav, et al.
Published: (2014-01-01)

Authors′ response
by: Santosh R Taur, et al.
Published: (2015-01-01)

An analysis of completeness and quality of adverse drug reaction reports at an adverse drug reaction monitoring centre in Western India
by: Manali Mangesh Mahajan, et al.
Published: (2018-01-01)

An audit of colistin use in neonatal sepsis from a tertiary care centre of a resource-limited country
by: Bonny Jasani, et al.
Published: (2016-01-01)

Has mandatory prospective registration of all studies brought about a change? A 1-year audit of studies registered in the Clinical Trials Registry of India [CTRI] before and after April 1, 2018
by: Nayana S Shetty, et al.
Published: (2021-01-01)

Cells and mediators of inflammation (C-reactive protein, nitric oxide, platelets and neutrophils) in the acute and convalescent phases of uncomplicated Plasmodium vivax and Plasmodium falciparum infection
by: Josué da Costa Lima-Junior, et al.
Published: (2012-12-01)

An audit of reporting of conflict of interest policies among three stakeholders in Indian biomedical journals
by: Debdipta Bose, et al.
Published: (2020-01-01)

Knowledge about clinical trial agreement and clinical trial related insurance among Ethics Committee members: A cross-sectional survey
by: Kannan Sridharan, et al.
Published: (2016-01-01)

Current status of standardized, quality and ethical oversight of clinical research in the country: An audit of the Central Drugs Standard Control Organization (registration of ethics committees) and national accreditation board for hospital and healthcare providers (accreditation) databases
by: Tushar Bhimrao Nishandar, et al.
Published: (2019-01-01)

An audit of the approval letters issued by Drugs Controller General of India to Ethics Committees in India
by: Shruti S Bhide, et al.
Published: (2016-01-01)

The Year Ahead: An initiative to assess the impact of an intervention "Speaking Book" on awareness among the potential participants about clinical trials in India
by: Urmila Thatte, et al.
Published: (2011-01-01)

Plasmodium vivax-induced Adult Respiratory Distress Syndrome
by: Arvind A Bamanikar, et al.
Published: (2013-01-01)

An evaluation of drug lag for new drugs approved by the Indian regulator relative to the United States, European Union, and Japanese regulatory agencies: A 15-year analysis (2004–2018)
by: Mahanjit Konwar, et al.
Published: (2021-01-01)

Factors influencing recruitment and retention of participants in clinical studies conducted at a tertiary referral center: A five-year audit
by: Debdipta Bose, et al.
Published: (2020-01-01)

The clinicopathologic manifestations of plasmodium vivax malaria in children
by: Hareesh Resu, et al.
Published: (2019-01-01)

Audiovisual recording of the consenting process in clinical research: Experiences from a tertiary referral center
by: Parvan A Shetty, et al.
Published: (2018-01-01)

Determination of reference intervals from a laboratory database of an academic clinical research unit in a tertiary care teaching hospital and an audit of out of range values
by: Brinal H Figer, et al.
Published: (2021-01-01)

Plasmodium vivax Malaria
by: Dhanpat K. Kochar, et al.
Published: (2005-01-01)

Malaric relapses due to Plasmodium Vivax Reinfección engógena por Plasmodium vivax
by: Cecilia Giraldo, et al.
Published: (1991-01-01)

On Illness, Convalescence and Rehabiliation
by: Helen Ramsdale
Published: (2003-01-01)

Book Review: How to Write the Thesis and Thesis Protocol: A Primer for Medical, Dental and Nursing Courses
by: Nithya Gogtay
Published: (2014-10-01)

Pimavanserin – drug review
by: Nithya Gogtay
Published: (2017-01-01)